Susan Hasty, Publisher
Table of Contents . . . March 14th, 2003
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Angiogenesis Weekly | Other Publications
Breast Cancer - High levels of growth factor could be marker for metastatic breast carcinoma
Cardiomyoplasty - Exogenous growth factors improve vascularity after surgery for heart failure
Cell Biology - Researcher explores tumors' survival strategy
Gynecological Oncology - Ovarian carcinoma contains endocrine gland-derived growth factor
Melanoma - Lymphangiogenesis is a progression marker in cutaneous melanoma
Type 1 Diabetes - Advanced glycation endproducts correlate with diabetes complications
Bioengineering - Fibroblast growth factor 2 promotes microvessel formation in a culture system
Cancer Research - Vascular and hematopoietic stem cells are novel antiangiogenesis targets
Cancer Therapy - The weekly administration of paclitaxel may be more advantageous
Cardiopulmonary Medicine - Protein modulates growth factor induction of pulmonary valve endothelial cells
Dermatology - Thrombospondin-1 is critical to hair follicle involution
Diabetic Nephropathy - Gene polymorphisms may carry a risk for kidney disease in diabetics
Drug Development - The novel tyrosine kinase inhibitor SU11248 targets tumor molecules
Endocrinology - DITPA stimulates angiogenic growth factors and coronary arteriolar growth
Gastric Cancer - Reactive oxygen species prevent normoxic degradation of factor in cancer cells
Gene Regulation - Oxygenase is involved in the control of genes
Glioma - The multidrug resistance phenotype is differential in brain tumors
Pancreatic Cancer - Stat3 activation regulates elements of cancer progression
Retinopathy - Certain proteins play role in retinal neovascularization and inflammation
Tumor Suppression - Fucoidan oversulfation enhances its antiangiogenic and antitumor properties
Wound Care - Polysaccharides from Angelica sinensis accelerate gastric ulcer healing
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.